Bright Ideas - CIN Feasibility Study
Recruiting now · Not applicable
Conditions studied: Acute Lymphoblastic Leukemia (ALL)
In brief
In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who do and do not receive problem-solving skill training. This is a novel approach to controlling an important and common treatment-related symptom.
Key facts
- Study ID
- NCT04929899
- Run by
- The Hospital for Sick Children
- People needed
- 75
- Starts
- 2022-03-01
- Expected to finish
- 2025-06-01
- Last updated by the study team
- 2025-01-31
Who can join
Age: 4 and older, up to 18. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age: ≥ 4 years (PeNAT validated in patients 4 to 18 yrs)
- newly diagnosed or recurrent disease: first diagnosis of ALL (i.e. non-relapsed) in maintenance therapy
- English, French or Spanish-speaking with an English, French or Spanish-speaking guardian (PeNAT available in these languages)
- without physical or cognitive impairments that preclude use of the PeNAT
- planned to receive PO 6-mercaptopurine
- not planned to receive IV, IM, SC or IT chemotherapy or oral or IV corticosteroids during the 7-day study period
Where it is running
- Children's Hospital Los Angeles — Los Angeles, California, United States (enrolling)
- Rutgers Cancer Institute — New Brunswick, New Jersey, United States (enrolling)
- Inova Children's Hospital — Falls Church, Virginia, United States (enrolling)
- Hospital for Sick Children — Toronto, Ontario, Canada (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.